45 results
Page 2 of 3
6-K
EX-4.1
kx4emijxkvtijwu
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
hy162aeqtba6otnwio
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
7rsfp22
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-4.1
3vi63y2id3w8cbsybx
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-5.2
3ckbgfeaqtqw2y0gu2
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
sr3egi 7yo0zec
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
t6a2v13
23 Jan 20
Annual report (foreign) (amended)
4:31pm
F-3
EX-5.1
kj799bq
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
EX-5.1
rfc 8o1wyax
7 Jun 19
Shelf registration (foreign)
3:31pm
F-3
EX-5.2
hkmxshh
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.1
yegn27
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.1
txeb 5ktyg
19 Feb 19
Asset Purchase Agreement
4:57pm
6-K
EX-99.2
c8g13
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
tkdudftw
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
hcijyw1g
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.2
cqnj9ry
19 Nov 18
Agreement and Plan of Merger
4:34pm